XClose

Positive Behaviour Support

Home
Menu

FAQs

Why has this intervention been chosen for this study?

PBS is a multicomponent intervention that aims to support people with learning disability who show challenging behaviour. PBS more specifically has developed into a training that takes into account the variety of environmental influences on behaviour rather than solely the internal drivers of it. We chose PBS because it has potential to reduce challenging behaviour in people with intellectual disabilities. Another study estimated that implementing PBS may lead to estimated savings of £2K per person treated. We aim to evaluate clinical and cost effectiveness of PBS and to standardise its application in clinical practice.

Who designed the study?

The study was designed by Dr Angela Hassiotis and other colleagues who are all members of the study research team.

What will happen to the people who will not be in the intervention arm?

All the participants who will not be in the intervention arm will receive usual treatment. In other words, their usual care will not be changed. Usual care means that participants will continue to see their psychiatrist or psychologist; receive support for daily activities and to attend health appointments; continue with any medications they take already or have other therapies as is appropriate. We will record information on what types of care each team offers so we can explore which aspects are most helpful.

Who oversees the trial?

Before the study was funded, an external group of researchers and clinicians with expert knowledge reviewed the proposal to ensure it was sound and would result in a scientifically valid answer.  The study processes have also been approved by an independent ethics committee.

The research team oversees the work. Throughout, two independent groups, a Trial Steering Committee and an independent Data Monitoring Committee will also meet on a regular basis to ensure the study is carried out at a high standard and is safe for the participants.

Who is funding the trial?

This study is funded by the National Institute for Health Research HTA Programme (project number 10/104/13).